All posts by imreal

Business: Executives

Event Clinics Announces Natasha Sprengers-Levine As COO

Leave a comment



WASHINGTON (PRWEB)

Event Clinics announced today the promotion of Natasha Sprengers-Levine to Chief Operating Officer (COO), effectively immediately. As COO, Ms. Sprengers-Levine will direct day-to-day operations throughout Event Clinics, with oversight of the Company’s customer facing product lines and partnerships.

Ms. Sprengers-Levine brings a proven ability to drive business growth along with exceptional market expertise to her work as COO. Since Ms. Sprengers-Levine’s addition to the Event Clinics team in 2017, the Company’s market share has grown exponentially, solidifying Event Clinics’ position as the leading provider of e-commerce solutions for elite equestrian activities.

Ms. Sprengers-Levine previous served as SVP of Strategic Partnerships, where she was instrumental in materially expanding the Company’s revenue across all Olympic equestrian disciplines in a $122B market, which resulted in solid topline growth quarter over quarter. As COO, she will continue to work closely with industry partners to ensure customer success.

“Natasha’s contributions have been instrumental in the company’s market expansion and success to date.    She is a visionary leader with an exceptional ability to deliver business results. Her proven skills in managing client facing operations, combined with her strategic thinking and industry expertise, makes her an outstanding fit for this position,” said Tara Swersie, CEO of Event Clinics.

“What I find most compelling about Event Clinics is its unique position in the equestrian marketplace. The Event Clinics platform is trusted by riders across disciplines to provide them with the tools to discover, schedule, and pay for top caliber activities. I am looking forward to the opportunity to expand our operational and customer success strategies to better serve our growing community of motivated equestrians through 2020,” said Ms. Sprengers- Levine.

Prior to joining Event Clinics in 2017, Ms. Sprengers-Levine served as Assistant Trainer at the well known Sprieser Sporthorse, where she successfully developed and launched new services to multiple satellite locations. Her leadership in the equestrian industry includes multiple awards as well as serving as the captain of the Intercollegiate Dressage Association team at the University of Vermont.

Ms. Sprengers-Levine earned a Bachelor’s of Arts degree in Political Science and Philosophy from University of Vermont in 2014. In addition to her professional achievements, Ms. Sprengers-Levine is also an accomplished author who regularly contributes to industry publications that include Dressage Today, USEventing, and Eventing Nation.

About EVENT CLINICS:

Event Clinics is a leading software services provider in the equestrian industry with more than 75,000 users worldwide. The Event Clinics platform offers software solutions for online event registration, promotion, and payment focused on top tier athletic opportunities. Event Clinics’ innovative ECInstantPay™ product enables businesses to easily collect digital payments without incurring merchant fees, eliminating time consuming manual transactions. Learn more about Event Clinics at http://www.eventclinics.com, on Facebook, Instagram or LinkedIn.

Share article on social media or email:

Health

Ankylosing Spondylitis; Understanding this Chronic Inflammatory Joint Disorder

Leave a comment


https://www.prweb.com/

Dr. Kaixuan Liu

Frequently called arthritis of the spine, the debilitating disease initially manifests itself as stiffness, transient pain and inflammation of tendons in the vertebrae of the neck and back, especially in the lowest portion of the spine where it meets the pelvis.


WEST ORANGE, N.J. (PRWEB)

Ankylosing spondylitis (AS) — like the name, “it’s a bit complicated,” says spinal surgeon Kaixuan Liu, MD, PhD, who notes that the chronic, inflammatory joint disorder is difficult to diagnose, and its causes still not clearly understood. Frequently called arthritis of the spine, the debilitating disease initially manifests itself as stiffness, transient pain and inflammation of tendons in the vertebrae of the neck and back, especially in the lowest portion of the spine where it meets the pelvis. If left untreated, the condition can prompt bone-spur formation. The spurs grow and eventually create bony bridges and fusion of vertebrae, making the spine less flexible and forcing a hunched-over posture that may impede breathing, says Dr. Liu, founder and medical director of the Atlantic Spine Center.

As the condition progresses, it affects other tendons and joints like the hips, elbows, knees, and Achilles tendon and various bodily systems, such as the eyes (uveitis), heart, gut, even the skin (psoriasis), Dr. Liu indicates. He refers to recent studies that show a higher risk of death from heart disease and stroke and a reported 50 percent increase in risk of blood clots in patients with AS.

“What happens in AS is that a patient’s immune system becomes dysfunctional and begins attacking healthy tissue in the joints and other areas of the body,” Dr. Liu explains. Bone spurs and spinal rigidity occur when the body attempts to quell inflamed tendons by building up calcium in affected areas.

AS appears to develop most often in younger men between their teen years and mid-40s, although some experts suspect the disease may be under-diagnosed in women.

Besides gender, other potential causative agents include genetic variants, alterations in the body’s immune system, ethnicity, family history and environmental factors, such as exposure to certain toxins and infections — even changes in the bacterial population that normally inhabits the colon, says Dr. Liu. A study published online in August 2019 in the journal Plos One contends AS patients are more likely to have had a history of previous inflammatory problems, such as tonsillitis and appendicitis.

The Arthritis Foundation reports that nearly a half million people in the United States struggle with AS, which is a form of spondyloarthritis and which gets its name from the Greek ankylose, meaning to fuse or grow together, and spondylos, which refers to vertebra. The disease was first described in the 1600s.

Although AS has no known cure, new treatment protocols are proving increasingly effective in controlling the disorder, especially in its initial stages, says Dr. Liu, who emphasizes the importance of early diagnosis by a spinal specialist or rheumatologist. Just this year (2019), the American College of Rheumatology partnered with the Spondylitis Association of America and the Spondyloarthritis Research and Treatment Network in issuing updated guidelines for the treatment, assessment and diagnosis of AS.

“AS is suspected as a potential diagnosis if a patient is 40 years of age or under, complains of back pain or pain in the upper buttocks that has persisted for several months, and indicates the pain lessens with exercise and worsens during rest,” Dr. Liu states. “Although no single test provides a definitive diagnosis of AS, magnetic resonance imaging, X-rays and ultrasound, as well as a blood evaluation, can help determine presence of ongoing inflammation, especially in the lower back and hips.

“Patients often go to multiple doctors before getting a correct diagnosis,” says Dr. Liu.

Over-the-counter non-steroidal anti-inflammatory medications, as well as physical therapy, are one way of controlling AS. As scientists learn more about the disease’s causative factors, new therapies, including medications targeting dysfunctional immune system cells that promote inflammation, are being developed, he says.

In advanced cases, surgery may be required to repair damaged hips and other joints. Less common is spinal surgery, which is usually reserved for correcting severe downward curving of the spine and other significant spinal deformities caused by the disorder, Dr. Liu says.

Meanwhile, Dr. Liu suggests lifestyle changes that AS patients can make to help control their disease:

  • Exercise regularly to maintain spinal flexibility and increase strength and mobility. Recommended “gentle,” but effective, exercises include walking and swimming.

  • Practice good posture when sitting, standing or walking; don’t slouch.

  • Sleep on a firm – not hard – mattress and use a pillow.

  • Stop smoking and reduce alcohol consumption. Recent research indicates smoking impairs patient response to medications for treating inflammatory arthritis.


Improve diet and drop the pounds. Extra weight puts added stress on spine and other joints already affected by disease.

Atlantic Spine Center is a nationally recognized leader for endoscopic spine surgery with several locations in NJ and NYC. http://www.atlanticspinecenter.com, http://www.atlanticspinecenter.nyc

Kaixuan Liu, MD, is a board-certified physician who is fellowship-trained in minimally invasive spine surgery at Atlantic Spine Center.

Share article on social media or email:

Technology: Computer

KnowBe4 Finds 96 Percent of Organizations Say Email Phishing Scams Pose Biggest Security Risk

Leave a comment


The threats aren’t going away any time soon – the bad guys are just getting more and more clever. That’s why it’s so important to build up your human firewall – your end users – to better protect your organization. -Stu Sjouwerman, CEO, KnowBe4


TAMPA BAY, Fla. (PRWEB)

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced the results of its 2019 Security Threats and Trends Report.

The KnowBe4 2019 Security Threats and Trends Report polled 600 organizations worldwide in mid-2019 on the major security issues they will face in the next 12 to 18 months. It covers security initiatives, how well organizations are equipped to deal with security threats, the most persistent security threats, ongoing challenges in security and more.

“This study shows us why it’s a really good idea to step your users through new-school security awareness training,” said Stu Sjouwerman, CEO, KnowBe4. “The threats aren’t going away any time soon – the bad guys are just getting more and more clever. That’s why it’s so important to build up your human firewall – your end users – to better protect your organization.”

Survey highlights include:

  • A majority of corporations – 86% – have proactively amplified security initiatives over the last year to combat the increase in cybersecurity attacks.

  • Nearly nine out of 10 businesses – 89% – say they’re currently better equipped to deal with security threats than they were in 2018.

  • Three quarters or 76% of organizations say the biggest and most persistent security threat comes from “the enemy from within” – careless end users – who regularly clicks on bad links, placing organizations at higher risk of falling victim to email phishing, ransomware, CEO fraud scams and various forms of malware.

  • 58% of organizations cite budgetary constraints as an ongoing challenge in upgrading security.


To read the full report, visit https://blog.knowbe4.com/knowbe4-2019-security-threats-and-trends-report-october-2019.

About KnowBe4

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, is used by more than 28,000 organizations around the globe. Founded by IT and data security specialist Stu Sjouwerman, KnowBe4 helps organizations address the human element of security by raising awareness about ransomware, CEO fraud and other social engineering tactics through a new-school approach to awareness training on security. Kevin Mitnick, an internationally recognized cybersecurity specialist and KnowBe4’s Chief Hacking Officer, helped design the KnowBe4 training based on his well-documented social engineering tactics. Tens of thousands of organizations rely on KnowBe4 to mobilize their end users as the last line of defense.

Number 161 on the 2019 Inc. 500 list, #34 on 2018 Deloitte’s Technology Fast 500 and #2 in Cybersecurity Ventures Cybersecurity 500. KnowBe4 is headquartered in Tampa Bay, Florida with European offices in England, the Netherlands, Germany and offices in Brazil, Australia, Japan, South Africa and Singapore.

Share article on social media or email:

Technology: Electronics

PROSHRED® St. Louis Announces New Shred Truck to be Added to Current Fleet

Leave a comment


News Image

With this new truck, we are going to be able to increase service to our current clients, service new clients and minimize the risk of downtime!


ST. LOUIS (PRWEB)

PROSHRED® St. Louis is excited to announce the acquisition of a Shred-Tech MDS-2 truck, arriving at the first of November. With the newest vehicle added to the fleet, this rapidly expanding franchise is poised to grow its client base dramatically. PROSHRED® St. Louis continues to be the area’s choice for professional, affordable paper shredding as it further sets itself apart from the competition with top of the line equipment and a proven history of reliable, secure document destruction services.

Known for its ease of maneuverability and revolutionary shredding capabilities, the addition of this newest mobile shredding vehicle takes the St. Louis franchise to the next level of service and customer satisfaction. With the expanded capacity and a wide coverage area, locally owned PROSHRED® St. Louis is taking on new customers looking for convenient, secure mobile document destruction services.

“With this new truck, we are going to be able to increase service to our current clients, service new clients and minimize the risk of downtime!” says owner Nguyen Violette, adding, “We could not make this investment without the great relationship and support of our current and past clients!”

For more than 30 years, PROSHRED® has provided businesses with on-site and off-site paper and electronic shredding services, offering some of the most convenient, secure, and cost-effective methods available on the market today. With over two dozen independent franchises operating all over the U.S., the company has been a pioneer in at-home and on-site document and electronics shredding. Both NAID certified and ISO 9001:2008 certified, locally owned PROSHRED® St. Louis specializes in the secure destruction of sensitive and proprietary files for businesses and individuals across Illinois and the greater St. Louis area. The newly expanded fleet of cutting-edge destruction vehicles allows the growing location to offer enhanced, flexible service at competitive rates, and the ability to handle on-site document shredding jobs of any size.

PROSHRED® St. Louis is committed to providing professional shredding solutions designed to fit the individual needs of local businesses and industries. With highly trained, experienced technicians, and North America’s only NAID AAA and ISO 9001 certified secure shredding process, PROSHRED® serves Illinois residents and businesses by safeguarding private information and maintaining legislative compliance. Destroying and recycling confidential documents and proprietary files on-site helps prevent data breaches, and protects the reputation of outstanding companies. With the growing fleet of mobile shred trucks, PROSHRED® St. Louis continues to lead the way in state of the art mobile shredding services. For more information about PROSHRED® St. Louis, visit: https://www.proshred.com/st-louis/

Share article on social media or email:

Society: Social Services

Take Steps to Protect Older Adults Against the Flu

Leave a comment



OMAHA, Neb. (PRWEB)

Fall is the season for ghosts and goblins but perhaps even scarier for seniors is the flu. Last winter’s flu season set a record as the longest in 10 years, hospitalizing an estimated 647,000 people and resulting in more than 61,000 deaths, according to the CDC. And unfortunately, the effects of the current flu season are already being felt. Though the flu “season” typically runs from October to May, the first week of September already saw the start of patient visits to influenza to outpatient clinics.

Although there is no way to predict exactly how bad the flu will be, these early signs are reason enough to take extra precaution this season. This is especially important for older adults who often are at heightened risk and are among the largest group affected. According to the CDC, approximately 70-90 percent of influenza-related deaths and 50-70 percent of influenza-related hospitalizations occur among adults 65 and older.

To protect themselves against the flu, seniors are encouraged to take preventative measures and watch for symptoms.

“The flu is different than the common cold,” said Lakelyn Hogan Gerontologist and Caregiver Advocate of Home Instead Senior Care. “Symptoms of the flu are more severe and include fever or chills, cough, sore throat, fatigue or vomiting. Our CAREGivers at Home Instead know how detrimental the virus can be to an older adult’s health and the importance of taking every precaution.”

Home Instead encourages older adults and their families to prepare for this season by using the following tips:


  • Schedule time for your loved one to get the flu vaccine. The flu shot reduces the risk of getting the virus and reduces the severity of the illness. It is recommended to get the flu shot early, ideally by the end of October. Family members and caregivers should also receive the vaccination.

  • Maintain a healthy diet. As noted by the CDC, human immune defenses become weaker with age, which makes older adults more susceptible to viruses and illness. However, increasing Vitamin C intake helps protect seniors before the virus attacks. Broccoli, spinach, strawberries, sweet potatoes, oranges and tomatoes are all high in Vitamin C.

  • Exercise regularly. Moderate exercise helps boost the immune system. A walk around the neighborhood or even staying active with household chores can help fight off symptoms of the flu.

  • Practice daily healthy habits. Simple things such as washing your hands, keeping your hands away from your face and staying away from people who are sick can go a long way to prevent illness and avoid hospitalizations.


The 2019-2020 flu shot is now available. A quadrivalent flu vaccine is being offered this year, which provides protection against four strains of the flu. Contact your health care provider, local urgent care clinic or pharmacy to see if they are administering the vaccine.

For more information on staying healthy this flu season, visit http://www.preventseniorhospitalizations.com.

ABOUT HOME INSTEAD SENIOR CARE

Founded in 1994 in Omaha, Nebraska, the Home Instead Senior Care® franchise network provides personalized care, support and education to enhance the lives of aging adults and their families. Today, the network is the world’s leading provider of in-home care services for seniors, with more than 1,200 independently owned and operated franchises that provide more than 80 million hours of care annually throughout the United States and 11 other countries. Local Home Instead Senior Care offices employ approximately 90,000 CAREGivers worldwide who provide basic support services that enable seniors to live safely and comfortably in their own homes for as long as possible. Home Instead Senior Care franchise owners partner with clients and their family members to help meet varied individual needs. Services span the care continuum – from providing personal care to specialized Alzheimer’s care and hospice support. Also available are family caregiver education and support resources.

Visit HomeInstead.com. Connect with us on Facebook and Twitter

Share article on social media or email:



health and fitness

Allergy Standards Announces the Appointment of Emma Coonan as Executive Assistant to CEO

Leave a comment


“Emma’s qualifications, training, and experience working with CEO’s at the highest level in addition to her work in the health and wellbeing field are a perfect combination for a scaling life sciences and digital health company, making a digital footprint on an international scale.”


DUBLIN (PRWEB)

Allergy Standards Limited (ASL) announced today the appointment of Emma Coonan as Executive Assistant to CEO.

Emma is responsible for supporting the efficient and effective management of day-to-day and strategic operations in the CEO’s office and across the business. Working closely with the CEO and the wider Allergy Standards team, Emma’s role includes process management, operational planning, and project management.

Emma has over twelve years’ experience in Executive Support, Senior Administration, and Event Management roles within corporate, academic, and not-for-profit sectors including Trinity Foundation, Trinity College Dublin; The Royal College of Physicians of Ireland; NCB Stockbrokers Ltd; Deloitte & Touche, and Chill insurance Ltd. Emma is an accredited Psychotherapist and has combined her work in the corporate arena with her private Psychotherapy practice for a number of years.

Emma graduated from National University of Ireland, Maynooth, with a BA (Hons) in Media Studies and English. Ongoing professional and personal development is a passion of Emma’s, and since graduating Emma has been awarded a HDip (Hons) in Counselling and Psychotherapy, an MA (Hons) in Psychotherapy, a Diploma in Event Management, and is a certified trainer in Training Delivery and Evaluation. Emma has enjoyed volunteer experience as a reviewer of children’s books for an award winning children’s literature platform and as a local community club leader in one of Ireland’s leading youth organisations.

“Emma’s qualifications, training, and experience working with CEO’s at the highest level in addition to her work in the health and wellbeing field are a perfect combination for a scaling life sciences and digital health company, making a digital footprint on an international scale,” said Dr. John McKeon, CEO.

Emma can be found hiking and walking at every opportunity, when she’s not searching for her next great read amongst the bookshops and stalls of Dublin.

“I am delighted to join the Allergy Standards team, and to be part of a company which is a leader in healthy lifestyles, excellence, and innovation. I am looking forward to working with John and the team to build towards the future,” said Emma Coonan.

About Allergy Standards

Allergy Standards Limited (ASL) mantra is design thinking and an innovation for healthier indoor air for the allergy aware consumer. As an independent, international certification company, it creates meaningful scientific standards for testing a wide range of products and services to determine their impact on improving indoor air quality. ASL’s intellectual property portfolio includes unique testing protocols and suitability specifications for products to be CERTIFIED asthma & allergy friendly®. ASL’s mission is to improve lives by empowering people create the healthiest possible indoor environment through science, education and innovation. Our vision is a world where all ER visits caused by exposure to avoidable indoor allergens are eliminated.

Share article on social media or email:

Industry: Healthcare

Sun Life Selects TreatGxplus as a Pharmacogenomic Solution for Employee Wellness

Leave a comment


TreatGx supports the development of personalized treatment plans and prescribed medication options. It is a remarkable solution that is changing how we can help patients recover more quickly.


VANCOUVER, British Columbia (PRWEB)

GenXys Health Care Systems is proud to share that Sun Life selected TreatGxplus as part of its disability management toolkit for plan sponsors. According to Sun Life, the goal is to help plan members get back to work faster and live healthier lives. The award-winning TreatGxplus solution, an advanced precision prescribing software including a pharmacogenetic test, is offered by LifeLabs, Canada’s largest diagnostic and laboratory company, in partnership with GenXys.

TreatGx, the precision prescribing application, presents over 40,000 prescription options and models out 250,000 drug interactions through its comprehensive and interactive online medication decision support engine. The cloud-based platform is accessible to patients and their healthcare providers across Canada and the United States.

“Identifying safe and effective medication options for the patient is the goal,” said Dr. Martin Dawes, a Professor of Family Medicine, Chief Scientific Officer of GenXys.”TreatGx helps us achieve that goal by supporting the development of personalized treatment plans and prescribed medication options. It is a remarkable solution that is changing how we can help patients recover more quickly.”

The adoption of pharmacogenetic solutions by leading insurance companies such as Sun Life and UnitedHealth Group reaffirms the growing role of genetics in primary care and across health systems. With the level of clinical utility and relevance provided by TreatGx, pharmacogenetics can now enable medication decision support at the point of care.

While the initial Sun Life deployment will focus on mental health and chronic pain, TreatGx covers 35+ conditions where there are high levels of pharmacogenetic evidence. Echoing the recent statement by the Association for Molecular Pathology, every health-related pharmacogenetic link in TreatGx is supported by the best clinical evidence. For clinical accuracy and relevance, the solution also includes other variables such as other conditions, concurrent medications, and biophysical data in its proprietary algorithms that set it apart from others.

Building on significant growth in Canada, GenXys is establishing its footprint in the US through strong strategic partnerships. It is also working with stakeholders from healthcare systems and labs to incorporate clinically relevant pharmacogenetics at the point of care for ‘nextgen’ prescribing.

“We are delighted that the inclusion of pharmacogenetics in primary care is becoming a reality on a mass scale. It is the most applicable and actionable use of genetics for increasing patient safety, improving population health, and reducing the cost of healthcare,” said Karl Pringle, CEO of GenXys.

About GenXys Health Care Systems Inc.

GenXys offers best-in-class precision prescribing solutions to solve healthcare’s most pressing challenges. Our precision prescribing software and pharmacogenetic solutions can prevent adverse drug reactions, a leading cause of death, and personalized drug selection to increase drug efficacy. Powering every prescription globally with our software improves patient safety, population health, and reduces healthcare costs.

For more information, please visit http://www.genxys.com.

Media Contact:

Jenny Lu

T: 206-408-3099

E: info(at)genxys(dot)com

LinkedIn: https://www.linkedin.com/company/genxys-health-care-systems/

Share article on social media or email:

Business: Executives

Kabbage Launches Kabbage Payments™ to Help Small Businesses Get Paid Faster

Leave a comment


News Image

Kabbage Payments not only expands our suite of products, but the very definition of our company. We deeply believe in the mission of small businesses and understand what they need to succeed—namely, more time building their businesses and less time worrying about cash flow.


ATLANTA (PRWEB)

Kabbage, Inc., a data and technology company providing small businesses cash flow solutions, announced the general availability of Kabbage Payments to its customers, a new payment-processing solution for small businesses that makes getting paid faster as simple as sending a text message. After a successful beta program, this release marks the first of several new products that Kabbage will launch in the upcoming months to enable small businesses to more efficiently and intelligently manage their cash flow.

Two-thirds of Kabbage’s more than 200,000 customers rely on invoicing to receive payments today and wait as long as 90 days to be paid. Leveraging technology that powers Kabbage’s fully automated working capital solution, Kabbage Payments drastically reduces the time required to receive payments in typical net-term invoicing. With Kabbage Payments, users are settling invoices as quickly as 24 hours.

Among the many features of Kabbage Payments, the new custom pay link solves a fundamental challenge for business owners relying on invoice payments. Kabbage Payments customers can create a unique URL for their business and send payment requests through texts, emails or the web to collect card payments securely and quickly. With more flexibility, the custom pay link eliminates the need to manually create new accounts, open new payment orders, and duplicate work for recurring invoices.

“My clients receive dozens—if not hundreds—of invoices a month, so it’s easy for them to pile up and be paid out all at once,” said Lee Brewer, owner of Lee Brewer Enterprise LLC, an advertising firm in New York. “For years, I’ve waited anywhere from 15 to 30 days to get paid for my work. Now, I send clients my Kabbage custom pay link through email or WhatsApp and get paid the next day. This has helped me collect so quickly my cash flow concerns were eliminated seemingly overnight.”

Kabbage Payments also includes:

  • Online invoicing: Quickly and easily create, send and manage invoices.

  • Convenient dashboard: See all payments activity in a single view.

  • Next-day deposits: Access the money you earn in 24 hours or less.*

  • No-fee invoicing: Send unlimited invoices and estimates for free with no monthly fees.

  • Only pay for card payments: Save with low costs at 2.9% + $.25 per credit card payment. Cash and check payments are always free.

  • Free customer support: Speak to a real person on Kabbage’s trusted customer support team.

“Mercator’s latest research shows 65% of small businesses prioritize ease of use when selecting a payments solution. The ability to receive funds through a simple URL matches the digital-first way most business owners operate today,” said Robert Misasi, CEO of Mercator Advisory Group. “Small businesses have a wide set of payment options today and Kabbage’s data connections and leadership in automating funding create a strong pairing to provide small businesses a unique cash flow management solution.”

“Since 2011, we’ve helped hundreds of thousands of small businesses access over $8 billion in funding. We know first-hand a primary need is to cover cash-flow gaps while waiting to be paid,” said Kabbage CEO Rob Frohwein. “Kabbage Payments not only expands our suite of products, but the very definition of our company. We deeply believe in the mission of small businesses and understand what they need to succeed—namely, more time building their businesses and less time worrying about cash flow.”

Kabbage Payments is now available to existing Kabbage customers with public availability coming soon. Any business owner may request early access at http://www.kabbage.com/payments/early-access.

About Kabbage

Kabbage, Inc., headquartered in Atlanta, has innovated a data and technology platform to provide small businesses automated cash flow solutions, including its online lending platform which allows small businesses to quickly access ongoing lines of credit up to $250,000. With more than 2 million live data connections to customers, its technology analyzes small businesses’ real-time data such as online sales, banking information, shipping activity and dozens of other sources to understand performance, to provide a fully automated funding decision in minutes. To date, Kabbage has provided more than 200,000 small businesses access to over $8 billion of working capital. Kabbage is funded and backed by leading investors, including the SoftBank Vision Fund, BlueRun Ventures, Mohr Davidow Ventures and others. All Kabbage U.S.-based loans are issued by Celtic Bank, a Utah-Chartered Industrial Bank, Member FDIC. Kabbage Payments, LLC, a subsidiary of Kabbage, Inc., is a registered Payment Service Provider/Payment Facilitator sponsored by Fifth Third Bank, N.A., Cincinnati, OH. For more information, please visit http://www.kabbage.com.

*Transactions that are processed by 5 p.m. ET will be deposited in your bank account the following banking day. Any transactions that are processed after 5 p.m. ET will be deposited in your bank account within 2 banking days. Settlement to your bank account may be delayed if transactions are flagged for review.

Share article on social media or email:

Health

Hemanext Announces Publication of Data Demonstrating Significant Benefits Following the Transfusion of Hypoxically Stored Red Blood Cells

Leave a comment


When we look at all of the data from our study, it appears that storing RBCs hypoxically could result in better transfusion patient outcomes. Pedro Cabrales, PhD, University of California, San Diego


LEXINGTON, Mass. (PRWEB)

Hemanext, a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of transfusion therapy, today announced the publication of clinically significant data in Shock, the official journal of the Shock Society.

According to data generated in animal studies, “Resuscitation from hemorrhagic shock via transfusion of hypoxically stored red blood cells (RBCs, which carry oxygen throughout the body and transport carbon dioxide to the lungs for exhalation), recovered cardiac function, restored hemodynamic stability and improved outcomes” when compared to conventionally stored blood.

The study authors explained that trauma accounts for ten percent of deaths worldwide and is the third most-common cause of death in the United States. Hemorrhagic shock due to the rapid and extreme loss of blood is responsible for approximately fifty percent of trauma deaths. Developing improved methods for treating hemorrhagic shock is a high priority for trauma physicians around the world.

“Conventional RBCs have long been the standard of care in trauma. However, oxidative damage occurs that could impact patient outcome. These new data by Williams et. al shows that hypoxically stored RBCs achieve multiple clinically important functional resuscitation goals with a significantly smaller volume and meeting the FDA benchmark of 24-hour RBC recovery,” said Tor Hervig, MD, PhD; founding member of the Traumatic Hemostasis and Oxygenation Research (THOR) Network; Chief Medical Officer, Blood bank, Haugesund Hospital: Senior Consultant, Haukeland University Hospital.

The oxidative structural and functional damage known as “storage lesions” can limit the effectiveness of RBCs when transfused into patients. In many cases, the damaged RBCs may lead to poor clinical outcomes for highly vulnerable patients, including people suffering from shock or who require repeated transfusions to treat conditions such as sickle cell anemia, thalassemia and myelodyplastic syndrome.

Researchers are exploring the benefits of storing RBCs in oxygen-starved containers to prevent oxidative damage to the cells due to the presence of oxygen. In this study, the authors observed the following significant differences in outcomes between hypoxically and conventionally stored red blood cells:

  • Approximately fifty percent less RBC volumes were required to resuscitate animals from hemorrhagic shock when transfusing hypoxically stored RBCs – the authors cited this as the principal finding of the study

  • Faster reduction of blood lactate levels in transfused animals with the hypoxically stored RBCs compared to levels detected in the conventionally stored RBCs – reduced lactate is a biomarker for increased oxygen delivery by the RBCs, which is particularly important for shock patients

  • Hypoxically stored RBCs produced a significantly smaller degree of organ and tissue damage compared to conventionally stored RBC to arrive at the same clinically relevant hemodynamic goal

  • Hypoxically stored RBCs restored mean arterial pressure (MAP) and vascular resistance compared to conventionally stored RBCs


“When we look at all of the data from our study, it appears that storing RBCs hypoxically could result in better transfusion patient outcomes,” said Principal Investigator Pedro Cabrales, PhD, Professor of Bioengineering, University of California, San Diego. “The potential to deliver a higher-quality red blood cell that improves patient recovery and expands the blood supply by reducing the number of transfused units will have a significant impact in those patients suffering from hemorrhagic shock.”

The researchers addressed the need for clinical trials to determine the safety and efficacy of hypoxically stored RBC transfusions in trauma patients with hemorrhagic shock. Hemanext is committed to supporting this ongoing research.

“This study, performed under the expert guidance of Dr. Pedro Cabrales, serves as an important milestone in our development program for hypoxically stored RBCs. We are delighted with the results and will continue to pursue our goal of bringing this new technology to patients everywhere,” said Hemanext President and CEO Martin Cannon.

Click here to access an abstract of the study.

ABOUT HEMANEXT

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of transfusion therapy. The company’s research and development efforts center on the study and future commercialization of hypoxically stored red blood cells (RBCs). HEMANEXT ONE®, our initial product offering, is designed to improve the quality of life for chronic and high-volume transfusion patients while reducing costs.

Visit Hemanext.com to learn more.

Share article on social media or email:

Science: Biology

Quick Healthcare Logistics Sponsors World Cord Blood Day 2019

Leave a comment


Leading transplant doctors and pioneering cellular therapy researchers to speak at World Cord Blood Day virtual event

Leading transplant doctors and pioneering cellular therapy researchers to speak at World Cord Blood Day virtual event

We’re excited to play a role in the research and development of cord blood derivative therapies by providing logistics supply chain solutions to cord blood, biotech, and pharmaceutical companies worldwide, said David Murphy, Executive VP of Quick’s Life Science Division.


NEW YORK (PRWEB)

World Cord Blood Day (WCBD) takes place on November 15, 2019, and will provide an opportunity for parents, doctors, nurses, and midwives to learn about the current and future uses of cord blood stem cells, and the potential cord blood has to save lives.

Cord blood is now being used to treat and cure over 80 different life-threatening diseases, including leukemia, lymphoma, and sickle cell anemia. It is also proving critical to new areas of regenerative medicine to potentially treat spinal cord injuries, cerebral palsy, autism, type 1 diabetes, and much more. Stem cells for transplants come from the blood of the umbilical cord collected after a baby is born.

Quick, the leading transportation provider of cord blood, stem cells, and umbilical cords is sponsoring WCBD for the third year and will host a session on how to safely transport cord blood and derivative therapies. Industry veterans David Murphy and Monroe Burgess of Quick will discuss the critical steps for safe and secure transit of umbilical cord cells. Since babies arrive in the world on their own time frame, the logistics of cord blood collection and transportation must be carefully planned to ensure integrity and viability.

“All of us at Quick are proud to sponsor World Cord Blood Day to help educate the healthcare community and expectant parents about the life-saving value of cord blood cells. We’re excited to play a role in the research and development of cord blood derivative therapies by providing logistics supply chain solutions to cord blood, biotech, and pharmaceutical companies worldwide,” said David Murphy, Executive VP of Quick’s Life Science Division.

For more information about World Cord Blood Day, organized by Save the Cord Foundation, visit https://www.worldcordbloodday.org/.

About Quick Specialized Healthcare Logistics

Quick is the trusted logistics leader for the healthcare and life science industry, serving the community for 40 years. Quick safely and quickly transports human organs and tissue for transplant or research, blood, blood products, cord blood, bone marrow, medical devices, and equipment, as well as cell and gene therapies.

Contact:    Marie T. Vigliarolo, SVP Marketing

The Quick Group

+1 (718) 995-3616 ext. 2207

marie_vigliarolo@qintl.com

About Save the Cord Foundation

Save the Cord Foundation (a 501c3 non-profit) was established to advance cord blood education. The Foundation provides non-commercial information to parents, health professionals, and the public regarding methods for saving cord blood, as well as current applications using cord blood and the latest research. Learn more at http://www.SaveTheCordFoundation.org.

Contact: Chris Ober, Executive Director

Save The Cord Foundation

+1 (520) 419 0269

216709@email4pr.com

Share article on social media or email: